Dr. Gymbro
←

#phenylcapsaicin

1 article
A wide, editorial-style still life photographed in soft natural window light on a pale oatmeal-colored linen surface. In the center-left, a small matte ceramic dish holds a modest pile of vivid red dried chili peppers and a few sliced fresh chilies, their glossy seeds catching the light. Beside it sits a minimalist amber glass capsule bottle without a label, with two translucent capsules spilled onto the linen, along with a tiny brass measuring spoon holding a pinch of fine orange-red powder.

On the right side of the frame, slightly out of focus, a worn black barbell rests across a wooden gym box, with a chalk-dusted steel plate leaning nearby. A small cloud of white chalk dust hangs delicately in the air, backlit by the light. A folded gray cotton gym towel and a simple stainless steel water bottle sit in the soft background.

In the foreground, a minimalist white notebook lies open with a clean hand-drawn line graph in thin black ink, with a small red dot marking one point. A mechanical pencil rests across the page.

The palette is warm and restrained: terracotta red, burnt orange, cream, charcoal, and muted sage green accents from a single leafy chili plant stem. Shallow depth of field, subtle film grain, gentle shadows, generous negative space at the top of the frame for a title overlay. Modern health and science journal aesthetic, calm, clean, tactile, and slightly moody, like a magazine feature on sports nutrition. No people, no text, no logos.
nutrition

Phenylcapsaicin pre‑workout: migliora gli squat in CrossFit e riduce i dolori muscolari

BY DR. GYMBRO ·

Un composto estratto dal peperoncino, la phenylcapsaicin, è stato testato in uno studio triplo cieco su 50 atleti di CrossFit. Una singola dose di 2,5 mg assunta 45 minuti prima dell’allenamento ha aumentato il carico e le ripetizioni negli squat post‑sessione, ha ridotto la perdita di altezza nei salti e ha attenuato il dolore muscolare a 24 e 48 ore. Tuttavia non ha influito sul WOD né su lattato, RPE o frequenza cardiaca. Due autori hanno dichiarato un conflitto di interesse con un marchio di integratori, e lo studio riguarda solo una dose acuta. Ecco cosa dimostrano i dati, cosa non dimostrano e chi potrebbe trarne realmente vantaggio.

This page is available in